Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Explore the benefits of time-restricted eating, a diet pattern that suggests fewer, regular meals and fasting periods could improve insulin resistance, brain health, and glycemic control, potentially reducing the risk of developing type 2 diabetes and obesity.
Endocrinology, Diabetes, Metabolism June 29th 2023
British Medical Journal
Explore how metformin, a widely accessible diabetes drug, might play a critical role in preventing long COVID when given during the acute phase of COVID-19.
Allergy & Immunology June 21st 2023
Semaglutide, a familiar medication for obesity and type 2 diabetes, might pave a new path in managing alcohol dependence. Unearth the potential of this medication, which could reshape our understanding of alcohol dependence treatment.
Endocrinology, Diabetes, Metabolism June 21st 2023
DentalReach
The invention of plant-based oral insulin, which provides a more secure and efficient substitute for insulin injections, marks a significant advancement in the management of diabetes. Investigate this ground-breaking strategy that could revolutionize accessibility to diabetes treatment worldwide.
Dentistry June 16th 2023
Diabetes Food Hub
The Diabetes Plate Method streamlines meal planning for diabetes management. Utilizing a 9-inch plate, it divides meal components into nonstarchy vegetables, lean proteins, and carbohydrates. An efficient tool for physicians to guide patient dietary habits effectively.
Endocrinology, Diabetes, Metabolism June 14th 2023
Pfizer’s diabetes drug, danuglipron, demonstrates comparable weight loss to Novo Nordisk’s Ozempic in a recent mid-stage trial. Explore how this breakthrough could shape the future of type 2 diabetes treatment and weight loss market.